Literature DB >> 24315959

The critical role of Sestrin 1 in regulating the proliferation of cardiac fibroblasts.

Gang Sun1, Ruicong Xue2, Fengjuan Yao2, Dan Liu2, Huiling Huang2, Cong Chen2, Yanhui Li2, Junyi Zeng2, Gaoxing Zhang3, Yugang Dong4, Chen Liu5.   

Abstract

The proliferation of cardiac fibroblasts is pivotal in the development of cardiac fibrosis. Sestrin 1, which functions as antioxidant, plays diverse roles in the regulation of proliferation and cellular injury that is induced by oxidative stress. However, little is known regarding the impact of Sestrin 1 on the proliferation of cardiac fibroblasts. In the present study, with knockdown of Sestrin 1 by siRNA, we surveyed the effect of Sestrin 1 on cardiac fibroblast proliferation. Downregulation of Sestrin 1 promotes Ang II-induced proliferation of cardiac fibroblasts, leading to increased DNA synthesis and collagen production. Moreover, in the absence of Ang II, a similar phenotype to the basal condition was detected with silencing of Sestrin 1. Further analysis of the pro-proliferating signals revealed that knockdown of Sestrin 1 significantly activated ERK1/2 and mTOR, meanwhile, downregulation of Sestrin 1 also enhanced the expression of collagen type I and CTGF, which play important role in the cardiac fibrosis. Consistent with the antioxidant property of Sestrin 1, we determined that the proliferation induced by silence of Sestrin 1 was accompanied by a remarkably enhanced production of reactive oxygen species (ROS). However, diminishing ROS by NAC, a potent antioxidant, could only partly repress the pro-proliferative effect of Sestrin 1-downregulation. Consequently, our study demonstrated that Sestrin 1 plays an important role in the proliferation of cardiac fibroblasts, and the effect could be partly mediated by decreased oxidative stress.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiotensin II; Cardiac fibroblasts; Proliferation; Reactive oxygen species; Sestrin 1

Mesh:

Substances:

Year:  2013        PMID: 24315959     DOI: 10.1016/j.abb.2013.11.011

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

Review 1.  New Insights Into the Role of mTOR Signaling in the Cardiovascular System.

Authors:  Sebastiano Sciarretta; Maurizio Forte; Giacomo Frati; Junichi Sadoshima
Journal:  Circ Res       Date:  2018-02-02       Impact factor: 17.367

2.  Sestrin 1 ameliorates cardiac hypertrophy via autophagy activation.

Authors:  Ruicong Xue; Junyi Zeng; Yili Chen; Cong Chen; Weiping Tan; Jingjing Zhao; Bin Dong; Yu Sun; Yugang Dong; Chen Liu
Journal:  J Cell Mol Med       Date:  2017-02-09       Impact factor: 5.310

3.  Upregulation of sestrins protect atriums against oxidative damage and fibrosis in human and experimental atrial fibrillation.

Authors:  Zengxiang Dong; Chaolan Lin; Yujiao Liu; Hongbo Jin; Hong Wu; Zhenjun Li; Liping Sun; Lu Zhang; Xi Hu; Yingying Wei; Chengcheng Wang; Wei Han
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

Review 4.  Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases.

Authors:  Mazhar Pasha; Ali H Eid; Assaad A Eid; Yves Gorin; Shankar Munusamy
Journal:  Oxid Med Cell Longev       Date:  2017-06-11       Impact factor: 6.543

5.  Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure.

Authors:  Guangyuan Gao; Weiwei Chen; Miao Liu; Xu Yan; Ping Yang
Journal:  Dis Markers       Date:  2019-12-02       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.